![](/img/cover-not-exists.png)
Cost-Effectiveness Analysis Comparing FOLFIRINOX and Nab-Paclitaxel (Abaraxane) Plus Gemcitabine For First-Line Treatment Of Patients with Metastatic Pancreatic Cancer from the US Societal Perspective
Cheng, W, Hay, JWVolume:
19
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2016.03.1607
Date:
May, 2016
File:
PDF, 57 KB
english, 2016